Clinical and prognostic implications of the initial response to aspirin in patients with acute coronary syndrome

American Journal of Cardiology

Volumn 108, Issue 8, 2011, Pages 1112-1118

  Spectre, Galia ^a   Mosseri, Morris ^a,b   Abdelrahman, Nader M ^c   Briskin, Elinor ^a   Bulut, Atilla ^a   Loncar, Sasa ^a   Varon, David ^a   Alcalai, Ronny ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BRAIN ISCHEMIA; DRUG FATALITY; DYSLIPIDEMIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SMOKING; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ADMINISTRATION, ORAL; ASPIRIN; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053976156     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.013     Document Type: Article

References (23)

1. A.D. Michelson Antiplatelet therapies for the treatment of cardiovascular disease Nat Rev Drug Discov 9 2010 154 169
2. T. Geisler, M. Kapp, K. Göhring-Frischholz, K. Daub, C. Dösch, B. Bigalke, H. Langer, C. Herdeg, and M. Gawaz Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart 94 2008 743 747 (Pubitemid 351744692)
3. M.D. Linden, M.I. Furman, A.L. Frelinger III, M.L. Fox, M.R. Barnard, Y. Li, K. Przyklenk, and A.D. Michelson Indices of platelet activation and the stability of coronary artery disease J Thromb Haemost 5 2007 761 765 (Pubitemid 46563575)
4. G. Campo, M. Valgimigli, D. Gemmati, G. Percoco, S. Tognazzo, G. Cicchitelli, L. Catozzi, P. Malagutti, M. Anselmi, C. Vassanelli, G. Scapoli, and R. Ferrari Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY study J Am Coll Cardiol 48 2006 2178 2185 (Pubitemid 44873056)
5. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, and M.V. Huisman Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Arch Intern Med 167 2007 1593 1599 (Pubitemid 47280339)
6. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, J.W. Jukema, and M.V. Huisman Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis Am Heart J 154 2007 221 231 (Pubitemid 47069129)
7. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin 'resistance' and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198 (Pubitemid 351212675)
8. T. Cuisset, C. Frere, J. Quilici, F. Barbou, P.E. Morange, T. Hovasse, J.L. Bonnet, and M.C. Alessi High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome J Thromb Haemost 4 2006 542 549
9. B. Pamukcu, H. Oflaz, A. Oncul, B. Umman, F. Mercanoglu, M. Ozcan, M. Meric, and Y. Nisanci The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events J Thromb Thrombolysis 22 2006 103 110 (Pubitemid 44473559)
10. I. Fuchs, M. Frossard, A. Spiel, E. Riedmller, A.N. Laggner, and B. Jilma Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2006 2547 2552 (Pubitemid 44741545)
11. B. Linnemann, J. Schwonberg, H. Mani, S. Prochnow, and E. Lindhoff-Last Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary J Thromb Haemost 6 2008 677 683 (Pubitemid 351404936)
12. D. Varon, R. Dardik, B. Shenkman, S. Kotev-Emeth, N. Farzame, I. Tamarin, and N. Savion A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions Thromb Res 85 1997 283 294 (Pubitemid 27143804)
13. B. Shenkman, N. Savion, R. Dardik, I. Tamarin, and D. Varon Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor Thromb Res 99 2000 353 361 (Pubitemid 30645689)
14. G. Spectre, A. Brill, A. Gural, B. Shenkman, N. Touretsky, E. Mosseri, N. Savion, and D. Varon A new point-of-care method for monitoring anti-platelet therapy: application of the cone and plate(let) analyzer Platelets 16 2005 293 299 (Pubitemid 40943924)
15. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965 (Pubitemid 36315537)
16. A.L. Frelinger, Y. Li, M.D. Linden, I. Tarnow, M.R. Barnard, M.L. Fox, and A.D. Michelson Aspirin 'resistance': role of pre-existent platelet reactivity and correlation between tests J Thromb Haemost 6 2008 2035 2044
17. E.I. Lev, R.T. Patel, K.J. Maresh, S. Guthikonda, J. Granada, T. DeLao, P.F. Bray, and N.S. Kleiman Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance J Am Coll Cardiol 47 2006 27 33 (Pubitemid 43005160)
18. A.L. Frelinger III, M.I. Furman, M.D. Linden, Y. Li, M.L. Fox, M.R. Barnard, and A.D. Michelson Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896 (Pubitemid 44297229)
19. P.C. Armstrong, A.R. Dhanji, A.T. Tucker, J.A. Mitchell, and T.D. Warner Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy J Thromb Haemost 8 2010 613 615
20. E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, G. Papuchis, B. Mautner, R. Corbalan, D. Radley, and E. Braunwald The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842 (Pubitemid 30643610)
21. G. Montalescot, J. Dallongeville, E. Van Belle, S. Rouanet, C. Baulac, A. Degrandsart, and E. Vicaut STEMI and NSTEMI: are they so different? 1 Year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry) Eur Heart J 28 2007 1409 1417 (Pubitemid 47343817)
22. B. Shenkman, S. Matetzky, P. Fefer, H. Hod, Y. Einav, A. Lubetsky, D. Varon, and N. Savion Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests Thromb Res 122 2008 336 345
23. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, J.M. Ten Berg, and C.M. Hackeng High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events J Thromb Haemost 8 2010 2140 2148